TF and neoplasm: The employment of TfR1 can be achieved by encapsulating chemotherapeutic drugs inside targeted liposomes crafted with the targeting molecule (Tf) to target Tf receptors; thus improving tumor targeting, drug specificity, and therapeutic efficacy while reducing systemic toxicity.